Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
60,725,503
-
Shares change
-
+3,399,925
-
Total reported value, excl. options
-
$841,047,934
-
Value change
-
+$47,458,127
-
Put/Call ratio
-
4.3%
-
Number of buys
-
59
-
Number of sells
-
35
-
Price
-
$13.85
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q2 2017
As of 30 Jun 2017 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 132 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 60,725,503 shares of stock of the company.
Largest 10 holders included FRANKLIN RESOURCES INC, FMR LLC, JANUS HENDERSON GROUP PLC, Broadfin Capital, LLC, Partner Fund Management, L.P., BlackRock Inc., BAKER BROS. ADVISORS LP, KINGDON CAPITAL MANAGEMENT, L.L.C., VANGUARD GROUP INC, and CARLSON CAPITAL L P.
This table shows 132 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.